Zileuton Mice Food Allergy Study
Coudl a Common Asthma Drug Prevent Food Allergy Reactions? New Research Offers Hope
Table of Contents
Food allergies are a growing concern, impacting millions and causing important anxiety for individuals and families. Current treatments largely focus on managing allergic reactions after they occur. But what if we could prevent the reaction in the first place? Exciting new research suggests a potential breakthrough, focusing not on the immune system’s response to allergens, but on how those allergens enter the body.
Blocking Allergens at the Gut Level: A novel Approach
Traditionally, food allergy treatment has centered around suppressing the immune system’s overreaction to food proteins. This new study, however, takes a different tack. Researchers at Northwestern University have discovered a pathway that controls how allergens cross the gut lining - and a potential way to block that passage.
“This is a totally different, out-of-the-box approach to treat food allergy, unlike anything we’ve tried before,” explains Dr. Williams, a researcher involved in the study. “For parents sending their child to a birthday party, or for anyone flying where they can’t control what’s being served, this could be a powerful protective drug.”
The research, published in Science, centers around a molecule called cysteinyl leukotriene. This molecule appears to loosen the tight junctions in the gut lining, allowing food allergens to pass through and trigger an immune response. By blocking this molecule, researchers were able to significantly reduce allergic reactions in mice.
Why Some People Seem “Allergic” But Don’t React
The findings also shed light on a puzzling phenomenon: why some individuals test positive for food allergies but experience no symptoms when consuming the allergen.”Let’s say you’re told you’re allergic to peanuts based on a blood test, but you’ve eaten peanuts your whole life without any problems,” says Dr. Eisenbarth, lead author of the study. “This pathway we discovered may be one description for why some of those people are protected.” It suggests that some individuals may have a naturally tighter gut barrier, or a less active cysteinyl leukotriene pathway, preventing allergen absorption.
Zileuton: From asthma Treatment to Allergy Prevention?
The drug used to block cysteinyl leukotriene in the study was zileuton, already FDA-approved for the treatment of asthma. This is a significant advantage,as it potentially fast-tracks the drug’s development for allergy prevention.
“If you’d asked me five or six years ago to guess the pathway that would lead to this revelation, I never would have picked this gene or the leukotriene molecules,” Dr.Eisenbarth admits.
Currently, a small clinical trial is underway to determine if zileuton has the same effect in humans. While the results are promising in mice, human gut biology can differ, and the drug’s efficacy and safety need to be confirmed. However, the potential for repurposing an existing drug offers a quicker path to market then developing a new one.
A New Understanding of Food Allergy Development
This research isn’t just about finding a treatment; it’s about fundamentally changing our understanding of how food allergies develop.
“Our findings open a whole new area for future research into how people develop food allergies in the first place,” Dr. Eisenbarth adds. Understanding the mechanisms behind allergen absorption could lead to preventative strategies, potentially reducing the incidence of food allergies altogether.
this discovery represents a significant step forward in the fight against food allergies, offering a glimmer of hope for a future where enjoying a meal isn’t a source of fear and anxiety.
Reference: Hoyt LR, Liu E, Olson EC, et al.Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice. Science. 2025. doi: 10.1126/science.adp0240
This article is a rework of a press release issued by Northwestern University. Material has been edited for length and content.